SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-413225
Filing Date
2014-11-14
Accepted
2014-11-14 16:10:49
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d806120d10q.htm 10-Q 364132
2 EX-31.1 d806120dex311.htm EX-31.1 8836
3 EX-31.2 d806120dex312.htm EX-31.2 8813
4 EX-32.1 d806120dex321.htm EX-32.1 3290
  Complete submission text file 0001193125-14-413225.txt   3167485

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT xbio-20140930.xml EX-101.INS 350779
6 XBRL TAXONOMY EXTENSION SCHEMA xbio-20140930.xsd EX-101.SCH 38575
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xbio-20140930_cal.xml EX-101.CAL 55202
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xbio-20140930_def.xml EX-101.DEF 100321
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE xbio-20140930_lab.xml EX-101.LAB 276294
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xbio-20140930_pre.xml EX-101.PRE 194207
Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7722
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-178082 | Film No.: 141224208
SIC: 2834 Pharmaceutical Preparations